Skip to main content

Published locations for Monotherapy Option for Type 2 Diabetes Patients : Muraglitazar effectively lowered hemoglobin A1c and triglycerides while raising HDL cholesterol levels.

Primary tabs

  • View
  • Get Stamp Tags
  • Published Locations

Breadcrumb

  1. Home
  3. Monotherapy Option for Type 2 Diabetes Patients : Muraglitazar effectively lowered hemoglobin A1c and triglycerides while raising HDL cholesterol levels.

User login

  • Reset your password
  • /content/monotherapy-option-type-2-diabetes-patients-muraglitazar-effectively-lowered-hemoglobin-a1c
  • /familypracticenews/article/26226/endocrinology/monotherapy-option-type-2-diabetes-patients
  • /familymedicine/article/26226/endocrinology/monotherapy-option-type-2-diabetes-patients-muraglitazar